toxin coregulated pilus
Recently Published Documents


TOTAL DOCUMENTS

41
(FIVE YEARS 0)

H-INDEX

24
(FIVE YEARS 0)

2017 ◽  
Vol 2 (4) ◽  
Author(s):  
Yi-Wei Chang ◽  
Andreas Kjær ◽  
Davi R. Ortega ◽  
Gabriela Kovacikova ◽  
John A. Sutherland ◽  
...  

2016 ◽  
Vol 12 (12) ◽  
pp. e1006109 ◽  
Author(s):  
Dixon Ng ◽  
Tony Harn ◽  
Tuba Altindal ◽  
Subramania Kolappan ◽  
Jarrad M. Marles ◽  
...  

2016 ◽  
Vol 24 (1) ◽  
Author(s):  
Leslie M. Mayo-Smith ◽  
Jakub K. Simon ◽  
Wilbur H. Chen ◽  
Douglas Haney ◽  
Michael Lock ◽  
...  

ABSTRACT One potential advantage of live attenuated bacterial vaccines is the ability to stimulate responses to antigens which are only expressed during the course of infection. To determine whether the live attenuated cholera vaccine CVD 103-HgR (Vaxchora) results in antibody responses to the in vivo-induced toxin-coregulated pilus antigen TcpA, we measured IgA and IgG responses to Vibrio cholerae O1 El Tor TcpA in a subset of participants in a recently reported experimental challenge study. Participants were challenged with V. cholerae O1 El Tor Inaba N16961 either 10 days or 90 days after receiving the vaccine or a placebo. Neither vaccination nor experimental infection with V. cholerae alone resulted in a robust TcpA IgG or IgA response, but each did elicit a strong response to cholera toxin. However, compared to placebo recipients, vaccinees had a marked increase in IgG TcpA antibodies following the 90-day challenge, suggesting that vaccination with CVD 103-HgR resulted in priming for a subsequent response to TcpA. No such difference between vaccine and placebo recipients was observed for volunteers challenged 10 days after vaccination, indicating that this was insufficient time for vaccine-induced priming of the TcpA response. The priming of the response to TcpA and potentially other antigens expressed in vivo by attenuated V. cholerae may have relevance to the maintenance of immunity in areas where cholera is endemic.


2016 ◽  
Vol 198 (20) ◽  
pp. 2818-2828 ◽  
Author(s):  
Yang Gao ◽  
Caitlyn A. Hauke ◽  
Jarrad M. Marles ◽  
Ronald K. Taylor

ABSTRACTVibrio choleraeis the etiological agent of the acute intestinal disorder cholera. The toxin-coregulated pilus (TCP), a type IVb pilus, is an essential virulence factor ofV. cholerae. Recent work has shown that TcpB is a large minor pilin encoded within thetcpoperon. TcpB contributes to efficient pilus formation and is essential for all TCP functions. Here, we have initiated a detailed targeted mutagenesis approach to further characterize this salient TCP component. We have identified (thus far) 20 residues of TcpB which affect either the steady-state level of TcpB or alter one or more TCP functions. This study provides a solid framework for further understanding of the complex role of TcpB and will be of use upon determination of the crystal structure of TcpB or related minor pilin orthologs of type IVb pilus systems.IMPORTANCEType IV pili, such as the toxin-coregulated pilus (TCP) inV. cholerae, are bacterial appendages that often act as essential virulence factors. Minor pilins, like TcpB, of these pili systems often play integral roles in pilus assembly and function. In this study, we have generated mutations intcpBto determine residues of importance for TCP stability and function. Combined with a predicted tertiary structure, characterization of these mutants allows us to better understand critical residues in TcpB and the role they may play in the mechanisms underlying minor pilin functions.


Sign in / Sign up

Export Citation Format

Share Document